TIDMAZN

RNS Number : 4400U

AstraZeneca PLC

01 August 2022

1 August 2022 15:05 BST

Transaction by Person Discharging Managerial Responsibilities

AstraZeneca PLC (the Company) announced that on 29 July 2022 awards of AstraZeneca American Depositary Shares (ADSs) vested to Dr Aradhana Sarin, Executive Director and Chief Financial Officer. Each ADS represents one half of an Ordinary Share of $0.25 in the Company.

In accordance with the Agreement and Plan of Merger between the Company and Alexion Pharmaceuticals, Inc. (Alexion), Dr Sarin's in-flight share awards granted by Alexion were converted to 2017 Incentive Plan.

Following the withholding of awards over AstraZeneca ADSs under the AstraZeneca Global Restricted Stock Plan at the time of closing of the Alexion acquisition. The awards that vested on 29 July 2022 replaced in-flight Alexion awards originally granted to Dr Sarin between February 2019 and February 2021 under the Alexion shares to satisfy certain tax obligations arising on vesting, 67,523 ADSs vested.

For tax purposes, the fair market value of an ADS at vest of the awards was US$66.72, being the closing price on the last trading day preceding the vesting.

Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law pursuant to the European Union (Withdrawal) Act 2018.

 
       Details of the person discharging managerial responsibilities 
  1     / person closely associated 
 a)    Name                             Aradhana Sarin 
      -------------------------------  ----------------------------------------- 
       Reason for the notification 
  2 
      -------------------------------------------------------------------------- 
 a)    Position/status                  Chief Financial Officer 
      -------------------------------  ----------------------------------------- 
 b)    Initial notification/Amendment   Initial notification 
      -------------------------------  ----------------------------------------- 
       Details of the issuer, emission allowance market participant, 
  3     auction platform, auctioneer or auction monitor 
      -------------------------------------------------------------------------- 
 a)    Name                             AstraZeneca PLC 
      -------------------------------  ----------------------------------------- 
 b)    LEI                              PY6ZZQWO2IZFZC3IOL08 
      -------------------------------  ----------------------------------------- 
       Details of the transaction(s): section to be repeated 
  4i    for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transactions 
        have been conducted 
      -------------------------------------------------------------------------- 
 a)    Description of the               AstraZeneca PLC American Depositary 
        financial instrument,            Shares 
        type of instrument 
 
        Identification code              CUSIP: 046353108 
      -------------------------------  ----------------------------------------- 
 b)    Nature of the transaction        Acquisition of AstraZeneca PLC American 
                                         Depository Shares pursuant to a vesting 
                                         under the Global Restricted Stock 
                                         Plan 
      -------------------------------  ----------------------------------------- 
 c)    Price(s) and volume(s)             Price(s)   Volume(s) 
                                           0          67,523 
                                                     ---------- 
      -------------------------------  ----------------------------------------- 
 d)    Aggregated information           Not applicable - single transaction 
 
        - Aggregated volume 
        - Price 
      -------------------------------  ----------------------------------------- 
 e)    Date of the transaction          29 July 2022 
      -------------------------------  ----------------------------------------- 
 f)    Place of the transaction         Outside a trading venue 
      -------------------------------  -----------------------------------------

AstraZeneca

AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialisation of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca .

Contacts

For details on how to contact the Investor Relations Team, please click here . For Media contacts, click here .

Adrian Kemp

Company Secretary

AstraZeneca PLC

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHUAOKRURUWRRR

(END) Dow Jones Newswires

August 01, 2022 10:05 ET (14:05 GMT)

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Astrazeneca Charts.
Astrazeneca (LSE:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Astrazeneca Charts.